Orum Therapeutics
Korea - Daejeon
Biotechnology1 H-1B visas (FY2023)Focus: Cell-Penetrating Antibodies
Orum Therapeutics is a life sciences company focused on Cell-Penetrating Antibodies.
Oncology
Open Jobs
3
Pipeline & Clinical Trials
ORM-5029
HER2-positive Breast CancerClinical Trials (1)
NCT05511844Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors
Phase 1Open Jobs (3)
Interview Prep Quick Facts
Portfolio: 1 clinical trial
H-1B (2023): 1 approval
Open Roles: 3 active jobs
Hiring Trend
Stable
3
Open Roles
+0
Added
-1
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub